Photographic products company Eastman Kodak fell 40% on the New York Stock Exchange on Monday after the U.S. government suspended a deal to produce generic drug ingredients in response to the COVID-19 pandemic. between allegations of insider trading.
The US International Financial Development Corporation indicated this weekend that these “allegations of misconduct raise serious concerns” in the federal government, which will not “continue until cleared up” with the $ 765 million loan to produce pharmaceutical supplies, which they intended to leave to depend on outside to manufacture them.
